Welcome to the all-new Vetlearn

  • Vetlearn is becoming part of NAVC VetFolio.
    Starting in January 2015, Compendium and
    Veterinary Technician articles will be available on
    NAVC VetFolio. VetFolio subscribers will have
    access to not only the journals, but also:
  • Over 500 hours of CE
  • Community forums to discuss tough cases
    and networking with your peers
  • Three years of select NAVC Conference
    Proceedings
  • Free webinars for the entire healthcare team

To access Vetlearn, you must first sign in or register.

registernow

  Sign up now for:
Become a Member

Compendium December 2009 (Vol 31, No 12)

Feline Struvite Urolithiasis

by Douglas Palma, DVM, DACVIM (Small Animal Internal Medicine), Cathy Langston, DVM, DACVIM (Small Animal Internal Medicine), Kelly Gisselman, DVM, DACVIM (Small Animal Internal Medicine), John McCue, DVM, DACVIM (Small Animal Internal Medicine, Neurology)

    CETEST This course is approved for 3.0 CE credits

    Start Test

    Abstract

    Feline urolithiasis represents 15% of all cases of nonobstructive lower urinary tract disease in cats. Approximately 50% of feline uroliths are composed of struvite. Struvite urolithiasis commonly recurs, but optimal management may decrease its frequency. The pathophysiology and management of struvite urolithiasis are different in cats and dogs. This article focuses on struvite urolithiasis in cats, highlighting important aspects of pathophysiology, treatment, and prevention.

    Pathophysiology

    The pathophysiology of struvite urolithiasis is different from that of other forms of urolithiasis. In general, the factors that influence the formation of a calculus include urine pH, renal mineral excretion, the presence of promoters, the absence of inhibitors, and the presence of infection or inflammation. In struvite urolithiasis, the concentration of struvite crystals free to react with other solutes in a solution, called the struvite activity product (SAP), also influences calculus formation. When the SAP increases to the point at which the urine becomes supersaturated, the crystals aggregate, forming uroliths. With further increases in SAP, spontaneous crystallization can occur.1

    Most canine struvite uroliths are caused by urinary tract infections. However, struvite uroliths are sterile in approximately 95% of feline cases. In cats, the formation of struvite uroliths is influenced by metabolic factors, including urine concentration, pH, and excess consumption or excretion of calculogenic minerals.2 An epidemiologic study3 that evaluated dietary risk factors for struvite and calcium oxalate urolithiasis found that increased magnesium, phosphorus, calcium, chloride, and fiber concentrations favored struvite formation in cats with existing urolithiasis compared with control animals without urolithiasis. As dietary fat content increased, struvite urolith formation was reduced. However, the interactions of minerals within the body may be more important than individual factors in altering the formation of struvite uroliths.3 It has been suggested that the dietary protein source may alter nitrogenous waste production, urinary acidification, and struvite formation. Additionally, protein may provide organic material that can act as a nidus for stone formation.4 Natural inhibitors such as citrate may reduce relative urinary supersaturation with struvite, similar to their suggested mechanism for reducing calcium oxalate formation.5

    Urinary pH is the most important factor in determining the SAP. Acidification of urine causes deprotonation of phosphates and increases the total proportion of urine phosphate existing as trivalent anions, reducing the SAP.6 Urinary pH and SAP have been reduced with both dietary modification and administration of urinary acidifiers.7 The solubility of struvite is maximized when the urinary pH is <6.4.5

    Other factors may contribute to struvite urolithiasis. Recently, it was shown that soluble proteins in feline urine act as promoters of struvite crystallization independent of SAP.8 The authors of this study suggested that reducing urinary protein excretion would be helpful in decreasing struvite crystallization and urolithiasis formation.

    Occasionally, infection can increase urinary ammonium concentration and pH, both of which may contribute to struvite urolithiasis, through urease production. Urease acts to convert urea to ammonia (NH3), which, through buffering of hydrogen ions, can result in formation of ammonium (NH4+). Ammonium directly contributes to struvite formation and indirectly facilitates nidus formation through local uroendothelial damage.

    Dietary moisture content has been reported to influence calcium oxalate urolith formation and the incidence of feline idiopathic cystitis, for which increased moisture may reduce supersaturation of crystallogenic substrates and urine concentration, respectively. Dietary moisture content has not definitively been shown to influence struvite calculus formation in cats.3

    Signalment

    There is no clear sex predilection.9,10 Although any breed can be affected, several breeds have an increased risk of struvite calculus formation, including the foreign shorthair, ragdoll, Chartreux, Oriental shorthair, domestic shorthair, and Himalayan (odds ratio: >2). Breeds noted to have a decreased risk include the rex, Abyssinian, Burmese, Russian blue, Birman, and Siamese, as well as mixed-breed cats (odds ratio: <0.5).11 Cats of all ages may develop struvite urolithiasis. The median age of cats with struvite calculi was 5.75 years in one study,11 which was significantly younger than cats with calcium oxalate calculi. Cats older than 4 years are 2.5 times more likely to develop struvite calculi compared with cats younger than 4 years. The highest incidence was seen in cats between 4 and 7 years of age, with a 10-fold greater risk compared with cats between 1 and 2 years of age. Infection-induced calculi were most common in cats younger than 1 year or older than 10 years.11

    Incidence

    Worldwide, urolithiasis has been reported in 15% to 23% of all cats with diseases of the lower urinary tract, and 22% to 50% of those uroliths are composed of struvite.2,9,12,13 Over the past 20 years, the ratio of calcium oxalate stones to struvite stones increased significantly, but it has recently reached a plateau. Struvite and calcium oxalate stones currently occur in almost equal proportions.14 Percentages of struvite submissions may not accurately reflect the true incidence of struvite calculi because of effective dissolution therapy without quantitative analysis. While most cases of lower urinary tract disease in cats are idiopathic cystitis, the management of this condition is different from urolithiasis.2,12

    Diagnosis

    Hematuria, pollakiuria, stranguria, and dysuria are common clinical signs of lower urinary tract disease and are not specific for cystic calculi. Most cats aged 1 to 10 years with lower urinary tract disease have idiopathic cystitis (55% to 64%). Urolithiasis accounts for 15% to 23% of cases of feline lower urinary tract disease; up to 11% of cases are due to anatomic defects; and 1% to 8% are urinary tract infections.12,13,15,16 In cats older than 10 years, 46% of lower urinary tract disease cases are related to infection and 17% to concurrent infection and calculi.17

    Alkaline urine increases the SAP and is commonly found in association with struvite urolithiasis. Crystalluria (FIGURE 1) without stone formation is not pathologic and can be found in healthy animals. In vitro crystal formation can occur as a result of prolonged storage, refrigeration, and alkalinization.18,19 Crystalluria can be confirmed by evaluation of fresh urine samples. Pyuria may result from concurrent infection. Urine culture via cystocentesis is recommended to evaluate for bacterial infection.

    Radiography is a sensitive test for detection of struvite calculi, which are radiopaque (FIGURE 2). If the calculi are small (<3 mm), ultrasonography or double-contrast cystography is superior to radiography for detection.2 Struvite uroliths tend to have smooth contours, but they vary in gross appearance (FIGURE 3).

    A history of struvite urolithiasis, struvite crystalluria, alkaline urine, and compatible radiographic features increases the suspicion for struvite urolithiasis, but definitive diagnosis is based on quantitative stone analysis. An algorithm for management of struvite urolithiasis is presented in FIGURE 4 .

    Treatment

    Therapy can be divided into stone dissolution and stone removal. Dissolution therapy has the benefits of avoiding major surgery, perioperative complications, and general anesthesia. Its disadvantages include treatment failure, reliance on owner and patient compliance, and costs associated with monitoring efficacy. BOX 1 lists patient selection criteria and other considerations for dissolution therapy. The potential for urethral obstruction as calculi become smaller exists; however, no literature supports dissolution as a risk factor for obstruction at this time.

    Dissolution therapy is effective in management of sterile feline struvite calculi. The key goals of dissolution diets include reduction in urine pH to ≤6.3 and reduction of dietary magnesium.20 One study21 found a mean dissolution time of 36 days (range: 14 to 141 days) for sterile uroliths and 44 days (range: 12 to 92 days) for infected uroliths when Hill's Prescription Diet s/d (Hill's Pet Nutrition) was used. Another commercially available dissolution diet (Medi-Cal Dissolution Formula, Veterinary Medical Diets, Guelph, Ontario) was effective in 79% of cases with clinical suspicion for sterile struvite.21 Treatment failure has been noted with mixed-composition calculi, owner noncompliance, and food refusal.22 Dissolution diets are not recommended for growing cats or for cats that are acidemic, pregnant, or hypervolemic because these diets are protein restricted and acidifying and can result in volume expansion from increased sodium concentration.20 Additionally, male cats may not be ideal candidates for dissolution therapy because of the chance of urethral obstruction.

    The selected diet should be fed exclusively. Radiographic evaluation at 3- to 4-week intervals is used to quantify changes in stone size and number (FIGURE 5). These diets should be continued for 2 to 4 weeks beyond radiographic resolution to ensure complete dissolution of calculi <3 mm, which are not radiographically visible.

    If a calculolytic diet is contraindicated (e.g., pregnancy, immaturity) or obstruction is present, physical removal of stones via surgical or nonsurgical techniques is recommended. Additionally, if infection is present, dissolution therapy is ineffective without antibiotic therapy. It is recommended that antibiotics be continued 1 month beyond radiographic dissolution, as bacteria can be released from calculi during therapy or can persistently colonize the uroendothelium and result in relapse.20,21 Infection-induced struvite uroliths generally take longer to dissolve than sterile struvite uroliths.21 In cats, nephroliths and ureteroliths are rarely composed of struvite and mostly composed of calcium oxalate. However, unlike feline struvite cystoliths, which are predominantly sterile, most feline struvite nephroliths (80%) are associated with urine culture results positive for urease-producing organisms.23,24

    Monitoring

    After definitive therapy, routine monitoring with urinalysis and abdominal radiography is recommended. Early detection of recurrence may allow nonsurgical therapies to be used. Cats with risk factors for urinary tract infections (i.e., chronic kidney disease, polyuria, diabetes mellitus, hyperthyroidism, perineal urethrostomy) should have urine samples cultured every 3 to 6 months.25-27 Monitoring urine pH is recommended to assess dietary compliance and efficacy. Values between 6.0 and 6.5 may reduce the incidence of calcium oxalate and struvite crystal formation. Monitoring urine specific gravity has been recommended to assess water consumption. A urine specific gravity <1.030 has been recommended as a goal.1,28

    Prevention

    A general recommendation for prevention of urolithiasis is to increase water consumption to encourage diuresis and reduce time for aggregation and crystallization (BOX 2). This may be most effectively completed with a transition to a moist diet; however, providing flavored or running water may encourage increased water intake.1

    Dietary therapy may reduce calculi recurrence, although clinical studies on recurrence rates are lacking. Epidemiologic studies suggest that a urine pH of approximately 6.0 to 6.3 and consumption of a low-magnesium diet reduce recurrence of naturally occurring sterile struvite urocystoliths.21,29 However, acidification of the urine to <6.29 may increase the risk of calcium oxalate urolith formation.30 Dietary analysis and quantification of "alkalogenic" and "acidifying" components may aid in predicting urine pH but cannot be recommended at this time.30

    Urinary acidifiers (dl-methionine, ammonium chloride) should be considered only when the urine pH is >6.5 with ad libitum feeding conditions.1 Urinary acidifiers alter the urine pH and SAP but cannot reduce the organic fraction responsible for the matrix formation.7

    Commercial diets designed to prevent struvite recurrence have not been critically evaluated in randomized, controlled studies. These diets may or may not influence the recurrence rates in clinical patients.

    Conclusion

    Struvite cystic calculi are common; dietary therapy is the mainstay of prevention. Diets with reduced magnesium that maintain a urine pH between 6 and 6.3 are recommended despite lack of evidence of efficacy. Struvite uroliths can be effectively medically dissolved or physically removed.

    Also on the Web

    Calcium Oxalate Urolithiasis (November 2009)

    Urate Urolithiasis (October 2009)

    Diagnosis of Urolithiasis (August 2008)

    Downloadable PDF

    1. Westropp JL, Buffington CA. Feline lower urinary tract disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 6th ed. Philadelphia: WB Saunders; 2005:1828-1850.

    2. Hostutler RA, Chew DJ, DiBartola SP. Recent concepts in feline lower urinary tract disease. Vet Clin North Am Small Anim Pract 2005;35:147-170.

    3. Lekcharoensuk C, Osborne CA, Lulich JP, et al. Association between dietary factors and calcium oxalate and magnesium ammonium phosphate urolithiasis in cats. JAVMA 2001; 219(9):1228-1237.

    4. Funaba M, Tanak T, Kaneko M. Fish meal vs. corn gluten meal as protein source for dry cat food. J Vet Med Sci 2001; 63(12):1355-1357.

    5. Yu S, Gross KL. Dietary management of the three most common lower urinary tract diseases in cats. Hill's Symp Lower Urinary Tract Dis 2007:53-57.

    6. Buffington CA, Rogers QR, Morris JG. Effect of diet on struvite activity product in feline urine. Am J Vet Res 1990; 51(12):2025-2030.

    7. Funaba M, Yamate T, Narukawa Y, et al. Effect of supplementation of dry cat food with D,L-methionine and ammonium chloride on struvite activity product and sediment in urine. J Vet Med Sci 2001;63(3):337-339.

    8. Matsumoto K, Funaba M. Factors affecting struvite (MgNH4PO4·6H2O) crystallization in feline urine. Biochim Biophys Acta 2008;1780(2):233-239.

    9. Houston DM. Feline urethral plugs and bladder uroliths: a review of 5484 submissions (1998-2003). Can Vet J 2003;44:974-977.

    10. Lekcharoensuk C, Lulich JP, Osborne CA, et al. Association between patient-related factors and risk of calcium oxalate and magnesium ammonium phosphate urolithiasis in cats. JAVMA 2000;217:520-525.

    11. Thumchai R, Lulich J, Osborne CA, et al. Epizootiologic evaluation of urolithiasis in cats: 349 cases (1982-1992). JAVMA 1996;208:547-551.

    12. Buffington CA, Chew DJ, Kendall MS, et al. Clinical evaluation of cats with non-obstructive urinary tract disease. JAVMA 1997;210:46-50.

    13. Geber B, Boretti FS, Kley S, et al. Evaluation of clinical signs and causes of lower urinary tract disease in European cats. Small Anim Pract 2005;46:571-577.

    14. Cannon AB, Westropp JL, Ruby AL, et al. Evaluation of trends in urolith composition in cats: 5,230 cases (1985-2004). JAVMA 2007;231(4):570-576.

    15. Lekcharoensuk C, Osborne CA, Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. JAVMA 2001;218:1429-1435.

    16. Kruger JM, Osborne CA, Goyal SM, et al. Clinical evaluation of cats with lower urinary tract disease. JAVMA 1991;199:211-216.

    17. Bartges JW, Blanco L. Bacterial urinary tract infection in cats. Stand Care Emerg Crit Care Med
    2001;3:1-5.

    18. Huston DM. Diagnosis and management of feline lower urinary tract disease. Stand Care Emerg Crit Care Med 2002;4:5-10.

    19. Albasan H, Lulich JP, Osborne CA, et al. Effects of storage time and temperature on pH, specific gravity, and crystal formation in urine samples from dogs and cats. JAVMA 2003;222:176-179.

    20. Osborne CA, Lulich JP, Thumchai R, et al. Diagnosis, medical treatment, and prognosis of feline urolithiasis. Vet Clin North Am 1996;26(3):589-627.

    21. Osbourne CA, Lulich JP, Kruger JM, et al. Medical dissolution of feline struvite urocystoliths. JAVMA 1996;196:1053-1063.

    22. Houston DM, Rinkardt NE, Hilton J. Evaluation of the efficacy of a commercial diet in the dissolution of feline struvite bladder uroliths. J Vet Ther 2004;5:187-201.

    23. Ling GV, Ruby AL, Johnson DL, et al. Renal calculi in dogs and cats: prevalence, mineral type, breed, age, and gender interrelationships (1981-1993). J Vet Intern Med 1998;12:11-21.

    24. Kyles AE, Hardie EM, Wooden BG, et al. Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in cats with ureteral calculi: 163 cases (1984-2002). JAVMA 2005;226(6):932-936.

    25. Mayer-Roenne B, Goldstein RE, Erb EN. Urinary tract infections in cats with hyperthyroidism, diabetes mellitus and chronic kidney disease. J Feline Med Surg 2007;9(2):124-132.

    26. Bailiff NL, Nelson RW, Feldman EC, et al. Frequency and risk factors for urinary tract infection in cats with diabetes mellitus. J Vet Intern Med 2006;20(4):850-855.

    27. Griffin DW, Gregory CR. Prevalence of bacterial urinary tract infection after perineal urethrostomy in cats. JAVMA 1992;200(5):681-684.

    28. Buffington CA, Chew DJ. Diet therapy in cats with lower urinary tract disorders. Vet Med 1999;
    94(7):626-630.

    29. Osborne CA, Lulich JP, Albasan H, et al. The role of nutrition in management of lower urinary tract disorders. Proc 21st ACVIM Forum 2003.

    30. Markwell PJ, Buffington CT, Smith BHE. The effect of diet on lower urinary tract diseases in cats. J Nutr 1998;128:2753S-2757S.

    References »

    NEXT: News Bite — Internet Popularity Among Pet Owners a Big Plus

    CETEST This course is approved for 3.0 CE credits

    Start Test

    didyouknow

    Did you know... Nonsurgical treatment of chylothorax can include pleural evacuation, dietary modifications, and various drug therapies or nutraceutical supplements.Read More

    These Care Guides are written to help your clients understand common conditions. They are formatted to print and give to your clients for their information.

    Stay on top of all our latest content — sign up for the Vetlearn newsletters.
    • More
    Subscribe